Pembrolizumab Plus Docetaxel Versus Docetaxel for Previously Treated Metastatic Castration-Resistant Prostate Cancer: The Randomized, Double-Blind, Phase III KEYNOTE-921 Trial
Merck Sharp & Dohme LLC
Daniel P Petrylak; Raffaele Ratta; Nobuaki Matsubara; Ernesto Korbenfeld; Rustem Gafanov; Loic Mourey; Tilman Todenhöfer; Howard Gurney; Gero Kramer; Andries M Bergman; Pawel Zalewski; Maria De Santis; Andrew J Armstrong; Winald Gerritsen; Russell Pachynski; Seok Soo Byun; Margitta Retz; Eric Levesque; Ray McDermott; Sergio Bracarda; Ray Manneh; Meital Levartovsky; Xin Tong Li; Charles Schloss; Christian H Poehlein; Karim Fizazi